Gio Juvenal Baracco, MD

Sylvester Comprehensive Cancer Center, part of the University of Miami Health System, is the only NCI-designated cancer center in South Florida, offering specialized care in oncology and a wide range of other medical specialties. The center is dedicated to providing world-class patient care through innovative treatments, research, and collaborative approaches among expert teams. In addition to cancer care, Sylvester Comprehensive Cancer Center features comprehensive services across various fields, including ophthalmology, neurology, and bariatrics, ensuring patients receive integrated and personalized medical attention. With a commitment to high-quality care, the facility emphasizes patient-centered approaches and the latest advances in medical research for effective treatment outcomes. Generated from the website

Dr Jimenez Jimenez, who joined the Division of Transplantation and Cell Therapy in 2016, leads Sylvester's Mismatched Allogeneic Transplant Program. His clinical and research work is dedicated to improving access to Hematopoietic Cell Transplantation (HCT) for ethnically diverse patients who lack suitable donors. A national leader in mismatched HCT, Dr Jimenez chairs multiple trials and played a key role in establishing Sylvester's program. He also focuses on strategies to reduce relapse risk in patients with acute leukemias and myeloid neoplasms post-transplant.

Dr Lekakis is a Professor of Medicine who joined the University of Miami in 2010 and became an attending physician for Hemotology/Oncology and Blood and Marrow Transplantation in 2012. He has since started the CAR-T trials, performed the first CAR-T for solid tumors, and transplanted adult sickle cell disease patients. Dr Lekakis is a member of the USA CAR-T Consortium and several CIBMTR committees including CAR-T, Lymphoma, Leukemia, and GVHD. His main interests are CAR-T and GVHD.